Classify supplier risk
Consider the material or service, product impact, data access, manufacturing role, regulatory history and ability to affect quality.
Outsourcing does not outsource responsibility for quality. A risk-based supplier quality program helps pharmaceutical and biotech companies qualify critical suppliers, assess performance and maintain appropriate oversight.
Consider the material or service, product impact, data access, manufacturing role, regulatory history and ability to affect quality.
Qualification may include questionnaires, documentation review, audits, quality agreements and evaluation of relevant certifications or inspection history.
A useful GMP audit should evaluate controls that matter to the sponsor, not simply produce a long checklist. Focus on systems, evidence and recurring risks.
Findings should describe the observed condition, evidence, relevant requirement or expectation and potential impact. Avoid vague observations that are difficult to remediate.
Supplier quality does not end when the audit report is issued. Track commitments, assess responses and escalate significant or recurring issues.
Use supplier performance, deviations, complaints, change notifications and audit history to determine whether the supplier's risk rating should change.